These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11055344)

  • 1. Novel, potent and selective chimeric FXa inhibitors featuring hydrophobic P1-ketoamide moieties.
    Semple JE; Levy OE; Minami NK; Owens TD; Siev DV
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2305-9. PubMed ID: 11055344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecotin is a potent anticoagulant and reversible tight-binding inhibitor of factor Xa.
    Seymour JL; Lindquist RN; Dennis MS; Moffat B; Yansura D; Reilly D; Wessinger ME; Lazarus RA
    Biochemistry; 1994 Apr; 33(13):3949-58. PubMed ID: 8142399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa.
    Gong Y; Pauls HW; Spada AP; Czekaj M; Liang G; Chu V; Colussi DJ; Brown KD; Gao J
    Bioorg Med Chem Lett; 2000 Feb; 10(3):217-21. PubMed ID: 10698439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors.
    Zhang P; Zuckett JF; Woolfrey J; Tran K; Huang B; Wong P; Sinha U; Park G; Reed A; Malinowski J; Hollenbach S; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1657-61. PubMed ID: 12039584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitors.
    Yoshikawa K; Yoshino T; Yokomizo Y; Uoto K; Naito H; Kawakami K; Mochizuki A; Nagata T; Suzuki M; Kanno H; Takemura M; Ohta T
    Bioorg Med Chem Lett; 2011 Apr; 21(7):2133-40. PubMed ID: 21345673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecotin: lessons on survival in a protease-filled world.
    McGrath ME; Gillmor SA; Fletterick RJ
    Protein Sci; 1995 Feb; 4(2):141-8. PubMed ID: 7757004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
    Guilford WJ; Shaw KJ; Dallas JL; Koovakkat S; Lee W; Liang A; Light DR; McCarrick MA; Whitlow M; Ye B; Morrissey MM
    J Med Chem; 1999 Dec; 42(26):5415-25. PubMed ID: 10639283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitors.
    Cacciola J; Fevig JM; Stouten PF; Alexander RS; Knabb RM; Wexler RR
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1253-6. PubMed ID: 10866393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and SAR of amino acid derivatives as factor Xa inhibitors.
    Su T; Wu Y; Doughan B; Jia ZJ; Woolfrey J; Huang B; Wong P; Park G; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2947-50. PubMed ID: 11677132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The de novo design and synthesis of cyclic urea inhibitors of factor Xa: initial SAR studies.
    Galemmo RA; Maduskuie TP; Dominguez C; Rossi KA; Knabb RM; Wexler RR; Stouten PF
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2705-10. PubMed ID: 9873607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors.
    Dudley DA; Bunker AM; Chi L; Cody WL; Holland DR; Ignasiak DP; Janiczek-Dolphin N; McClanahan TB; Mertz TE; Narasimhan LS; Rapundalo ST; Trautschold JA; Van Huis CA; Edmunds JJ
    J Med Chem; 2000 Nov; 43(22):4063-70. PubMed ID: 11063603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extended interactions and Gla domain of blood coagulation factor Xa.
    Wang SX; Hur E; Sousa CA; Brinen L; Slivka EJ; Fletterick RJ
    Biochemistry; 2003 Jul; 42(26):7959-66. PubMed ID: 12834348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and activity of a novel series of factor Xa inhibitors: optimization of arylamidine groups.
    Phillips G; Guilford WJ; Buckman BO; Davey DD; Eagen KA; Koovakkat S; Liang A; McCarrick M; Mohan R; Ng HP; Pinkerton M; Subramanyam B; Ho E; Trinh L; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 2002 Jun; 45(12):2484-93. PubMed ID: 12036356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors.
    Maduskuie TP; McNamara KJ; Ru Y; Knabb RM; Stouten PF
    J Med Chem; 1998 Jan; 41(1):53-62. PubMed ID: 9438022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors.
    Heinelt U; Herok S; Matter H; Wildgoose P
    Bioorg Med Chem Lett; 2001 Jan; 11(2):227-30. PubMed ID: 11206465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA.
    Choi-Sledeski YM; Becker MR; Green DM; Davis R; Ewing WR; Mason HJ; Ly C; Spada A; Liang G; Cheney D; Barton J; Chu V; Brown K; Colussi D; Bentley R; Leadley R; Dunwiddie C; Pauls HW
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2539-44. PubMed ID: 10498204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonbenzamidine tetrazole derivatives as factor Xa inhibitors.
    Quan ML; Ellis CD; He MY; Liauw AY; Woerner FJ; Alexander RS; Knabb RM; Lam PY; Luettgen JM; Wong PC; Wright MR; Wexler RR
    Bioorg Med Chem Lett; 2003 Feb; 13(3):369-73. PubMed ID: 12565931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577.
    Shi Y; Li C; O'Connor SP; Zhang J; Shi M; Bisaha SN; Wang Y; Sitkoff D; Pudzianowski AT; Huang C; Klei HE; Kish K; Yanchunas J; Liu EC; Hartl KS; Seiler SM; Steinbacher TE; Schumacher WA; Atwal KS; Stein PD
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6882-9. PubMed ID: 19896847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.
    Fevig JM; Pinto DJ; Han Q; Quan ML; Pruitt JR; Jacobson IC; Galemmo RA; Wang S; Orwat MJ; Bostrom LL; Knabb RM; Wong PC; Lam PYS ; Wexler RR
    Bioorg Med Chem Lett; 2001 Mar; 11(5):641-5. PubMed ID: 11266160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.
    Shi Y; O'Connor SP; Sitkoff D; Zhang J; Shi M; Bisaha SN; Wang Y; Li C; Ruan Z; Lawrence RM; Klei HE; Kish K; Liu EC; Seiler SM; Schweizer L; Steinbacher TE; Schumacher WA; Robl JA; Macor JE; Atwal KS; Stein PD
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7516-21. PubMed ID: 22041058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.